Manage My Pain at Chronic Pain Clinics in Urban, Community, and Rural Hospitals
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 246
- 试验地点
- 2
- 主要终点
- Evaluating engagement based on adoption and retention rates
研究概览
简要总结
The overall objective of this Early Adoption project is to gather evidence for how Managing My Pain Program (MMP), a novel digital pain management application can enable better care at home for chronic pain sufferers in the province of Ontario, Canada across 4 sites in urban, community, and rural settings
详细描述
Chronic pain imposes a large burden on individuals and society. A patient-centric digital chronic pain management application, Managing My Pain Program (MMP) that incorporates validated questionnaires can be used to enhance communication between providers and patients and promote self-management to evaluate the extent of patient engagement with the app when used in clinical settings.
The main objectives for this project is to evaluate the engagement in patients using MMP, and to assess improvements in clinical outcomes directly relevant for pain management, as measured by clinically-validated tools.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •New patients with chronic pain conditions referred to participating sites with pain programs to adopt the MMP tool into clinical practice.
排除标准
- •Patients declining to consent for the study
- •Patients withdrawing from the study at a later time after consenting
结局指标
主要结局
Evaluating engagement based on adoption and retention rates
时间窗: 24 months
Evaluating the number of patients who elected to use the Manage My Pain (MMP) application, and determining how long they used the app in the short-term (4.5 months) and long-term (4.5-7 months) follow-ups
次要结局
- Change in depression as measured by the Patient Health Questionnaire 9-item (PHQ-9)(Short-term (4.5 months) and long-term (4.5-7 months))
- Change in anxiety as measured by the General Anxiety Disorder 7-item Questionnaire (GAD-7)(Short-term (4.5 months) and long-term (4.5-7 months))
- Change in pain disability as measured by the Pain Disability Index (PDI)(Short-term (4.5 months) and long-term (4.5-7 months))
- Change in pain catastrophizing and measured by the Pain Catastrophizing Scale (PCS)(Short-term (4.5 months) and long-term (4.5-7 months))
- Change in opioid consumption as measured by Oral Morphine Equivalents (OME)(Short-term (4.5 months) and long-term (4.5-7 months))
- Change in patient satisfaction as measured by the Patient Global Impression of Change (PGIC) scale(Short-term (4.5 months) and long-term (4.5-7 months))